42225UAD6 Competition

Bonds . USA . 
Bond . HEALTHCARE TR AMER
42225UAD6   95.97  1.72  1.76%   
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
95.6795.9796.27
Details
Intrinsic
Valuation
LowRealHigh
91.5891.88105.57
Details
Naive
Forecast
LowNextHigh
94.5294.8195.11
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
94.5197.1199.72
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as 42225UAD6. Your research has to be compared to or analyzed against 42225UAD6's peers to derive any actionable benefits. When done correctly, 42225UAD6's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in HEALTHCARE TR AMER.

42225UAD6 Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between 42225UAD6 and its competitors represents the degree of relationship between the price movements of corresponding bonds. A correlation of about +1.0 implies that the price of 42225UAD6 and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of HEALTHCARE TR AMER does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
IONQ
+ 0.95
NDAQ
PYPL
+ 0.94
VRT
DIS
+ 0.93
IONQ
DIS
+ 0.9
NDAQ
NVDA
+ 0.89
VRT
IONQ
+ 0.88
VRT
  
High negative correlations   
PFE
- 0.89
IONQ
PFE
- 0.87
DIS
PFE
- 0.85
NDAQ
PFE
- 0.7
VRT
PFE
- 0.65
PYPL
PFE
- 0.59
NVDA

Risk-Adjusted Indicators

There is a big difference between 42225UAD6 Bond performing well and 42225UAD6 Corporate Bond doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze 42225UAD6's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
00108WAF7  1.31  0.10  0.01  0.38  1.57 
(1.42)
 3.24 
(2.55)
 10.75 
90331HPL1  0.32 (0.06) 0.00 (0.26) 0.00 
 0.00 
 0.32 
(0.85)
 6.98 
NDAQ  0.79  0.16  0.12  0.37  0.74 
(0.90)
 1.86 
(1.73)
 5.20 
VRT  2.39  0.61  0.23  0.43  2.36 
(2.65)
 5.87 
(4.39)
 20.36 
IONQ  5.74  2.13  0.43  1.01  4.08 
(6.89)
 16.30 
(6.53)
 47.83 
NVDA  2.18  0.01  0.01  0.13  3.11 
(2.10)
 4.07 
(4.69)
 12.87 
MSFT  0.90 (0.03)(0.04) 0.07  1.49 
(0.86)
 2.09 
(1.85)
 8.19 
PYPL  1.41  0.15  0.10  0.25  1.54 
(1.54)
 3.52 
(2.75)
 10.05 
DIS  0.98  0.27  0.21  0.57  0.61 
(1.11)
 2.34 
(1.38)
 7.57 
PFE  1.03 (0.20) 0.00 (0.37) 0.00 
 0.00 
 2.17 
(2.45)
 8.17 
All Fundamental Data

42225UAD6 Competitive Analysis

The better you understand 42225UAD6 competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, 42225UAD6's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across 42225UAD6's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
42225UAD6 00108WAF7 90331HPL1 NDAQ VRT IONQ NVDA MSFT PYPL DIS
 1.76 
 95.97 
42225UAD6
 9.51 
 82.21 
00108WAF7
 3.64 
 95.96 
90331HPL1
 1.39 
 82.65 
Nasdaq
 0.22 
 131.74 
Vertiv
 0.74 
 30.65 
IONQ
 0.66 
 136.92 
NVIDIA
 0.96 
 423.86 
Microsoft
 0.95 
 86.94 
PayPal
 1.39 
 117.05 
Disney
Market Volatility
(90 Days Market Risk)
Very steady
Out of control
Very steady
Very steady
Very steady
Somewhat reliable
Very steady
Very steady
Very steady
Very steady
Market Performance
(90 Days Performance)
Very Weak
OK
Very Weak
Solid
Solid
Solid
OK
Insignificant
Good
Solid
Odds of Financial Distress
(Probability Of Bankruptcy)
Below Average
Below Average
Below Average
Low
Low
Below Average
Low
Low
Low
Low
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Buy
Strong Buy
Buy
Strong Buy
Strong Buy
Buy
Strong Buy
Trade Advice
(90 Days Macroaxis Advice)
Cautious Hold
Strong Hold
Cautious Hold
Strong Hold
Strong Buy
Hold
Strong Sell
Strong Hold
Buy
Strong Buy
Current Ratio
N/A
N/A
N/A
0.96
1.62
30.11
3.39
1.84
1.27
1.0
Net Asset
N/A
N/A
N/A
32.29 B
8 B
555.43 M
65.73 B
512.16 B
82.17 B
196.22 B
Profit Margin
N/A
N/A
N/A
0.14
0.0772
N/A
0.55
0.36
0.14
0.053
EBITDA
N/A
N/A
N/A
2.16 B
1.02 B
(147.38 M)
35.58 B
133.01 B
6.83 B
14.01 B
Operating Margin
N/A
N/A
N/A
0.26
0.18
-4.29
0.62
0.47
0.18
0.15
Current Valuation
N/A
N/A
N/A
56.64 B
51.67 B
6.35 B
3.3 T
3.1 T
85.22 B
251.81 B
Price To Book
N/A
N/A
N/A
4.23
27.26
15.22
50.55
10.82
4.32
2.08
Retained Earnings
N/A
N/A
N/A
7.83 B
(691.9 M)
(352.07 M)
29.82 B
173.14 B
23.2 B
49.72 B
Current Asset
N/A
N/A
N/A
3.26 B
N/A
N/A
6.05 B
139.66 B
20.65 B
16.97 B
Five Year Return
N/A
N/A
N/A
1.57
N/A
N/A
0.2
1.18
N/A
1.38
Beta
N/A
N/A
N/A
0.96
1.59
1.89
1.66
0.9
1.44
1.4
Number Of Employees
N/A
N/A
N/A
9.12 K
27 K
324
29.6 K
228 K
27.2 K
173.25 K
Shares Outstanding
N/A
N/A
N/A
574.76 M
375.34 M
216.39 M
24.49 B
7.43 B
1 B
1.81 B
Cash Flow From Operations
N/A
N/A
N/A
1.7 B
900.5 M
(78.81 M)
28.09 B
118.55 B
4.84 B
13.97 B
Annual Yield
N/A
N/A
N/A
0.0118
0.0011
N/A
3.0E-4
0.0078
N/A
0.0082
Total Debt
N/A
N/A
N/A
10.87 B
3.13 B
8.11 M
11.06 B
97.85 B
9.68 B
45.81 B
Return On Equity
N/A
N/A
N/A
0.11
0.33
-0.37
1.24
0.36
0.22
0.0546
Return On Asset
N/A
N/A
N/A
0.0439
0.0932
-0.25
0.55
0.15
0.0434
0.0362
Number Of Shares Shorted
N/A
N/A
N/A
5.01 M
16.66 M
38.02 M
246.4 M
62.52 M
22.3 M
17.54 M
Book Value Per Share
N/A
N/A
N/A
19.26
4.83
2.02
1.74
38.69
20.05
55.41
Current Liabilities
N/A
N/A
N/A
2.92 B
N/A
N/A
2.35 B
59.36 B
13.62 B
16.84 B
Total Asset
N/A
N/A
N/A
32.29 B
8 B
555.43 M
65.73 B
512.16 B
82.17 B
196.22 B
Debt To Equity
N/A
N/A
N/A
0.99
2.68
0.007
0.56
0.44
0.56
0.45
Short Ratio
N/A
N/A
N/A
1.83
2.55
1.34
1.01
2.58
2.12
2.29
Target Price
N/A
N/A
N/A
81.83
141.42
18.58
170.44
504.77
89.87
121.67
Last Dividend Paid
N/A
N/A
N/A
0.92
0.1
N/A
N/A
3.08
N/A
N/A
Shares Owned By Institutions
N/A
N/A
N/A
85.48
87.33
36.89
66.1
73.54
74.94
69.77
Market Capitalization
N/A
N/A
N/A
47.5 B
49.45 B
6.63 B
3.35 T
3.18 T
87.16 B
209.07 B
Price To Earning
N/A
N/A
N/A
10.92
N/A
N/A
41.94
26.64
40.65
56.03
Price To Earnings To Growth
N/A
N/A
N/A
4.37
1.2
-1.01
0.86
2.21
1.47
1.02
Price To Sales
N/A
N/A
N/A
6.77
6.57
177.01
34.82
12.52
2.77
2.32
Net Income
N/A
N/A
N/A
1.06 B
460.2 M
(157.77 M)
29.76 B
88.14 B
4.25 B
5.77 B
Earnings Per Share
N/A
N/A
N/A
1.66
1.5
-0.82
2.53
12.11
4.18
2.72
Shares Owned By Insiders
N/A
N/A
N/A
10.72
0.91
9.83
4.2
0.056
0.22
N/A
Revenue
N/A
N/A
N/A
6.06 B
6.86 B
22.04 M
60.92 B
245.12 B
29.77 B
91.36 B
Working Capital
N/A
N/A
N/A
71 M
1.7 B
352.82 M
33.71 B
34.45 B
14.1 B
(9.36 B)
Cash And Equivalents
N/A
N/A
N/A
430 M
260.6 M
423.35 M
13.14 B
34.7 B
10.85 B
14.18 B
Cash Per Share
N/A
N/A
N/A
0.88
0.76
2.12
5.34
14.39
9.52
6.52
Gross Profit
N/A
N/A
N/A
3.58 B
1.62 B
1.1 M
44.3 B
165.36 B
11.65 B
29.7 B
Day Typical Price
95.97
82.21
95.96
82.26
132.48
31.07
137.3
423.94
87.34
116.51
Accumulation Distribution
N/A
N/A
N/A
0.0234
0.0385
0.0962
0.0261
0.0236
0.0145
0.0138
Market Facilitation Index
N/A
N/A
N/A
1.94
5.22
3.16
3.63
10.11
1.28
1.61
Daily Balance Of Power
(9,223,372,036,855)
9.2 T
(9,223,372,036,855)
0.5825
(0.06)
(0.07)
0.2479
(0.41)
(0.65)
0.9938
Period Momentum Indicator
(1.72)
7.14
(3.62)
1.13
(0.29)
(0.23)
0.9
(4.13)
(0.83)
1.6
Rate Of Daily Change
0.98
1.1
0.96
1.01
1.0
0.99
1.01
0.99
0.99
1.01
Day Median Price
95.97
82.21
95.96
82.07
132.85
31.28
137.49
423.99
87.54
116.25
Price Action Indicator
(0.86)
3.57
(1.81)
1.15
(1.25)
(0.75)
(0.12)
(2.19)
(1.02)
1.6
Relative Strength Index
44.96
55.06
41.17
69.53
64.21
70.06
52.41
53.68
61.43
78.49
Coefficient Of Variation
(14,511)
1325.26
(2,693)
404.84
404.96
319.91
1787.77
2031.82
619.47
398.7
Mean Deviation
0.2874
1.31
0.3166
0.7852
2.39
5.74
2.18
0.8978
1.41
0.98
Jensen Alpha
(0.01)
0.0996
(0.06)
0.1605
0.61
2.13
0.0118
(0.03)
0.1494
0.2743
Total Risk Alpha
(0.14)
(0.18)
(0.18)
0.0803
0.2994
1.2
(0.31)
(0.15)
(0)
0.1232
Sortino Ratio
N/A
0.014
N/A
0.1183
0.2319
0.4324
0.0099
(0.04)
0.0968
0.2115
Downside Variance
N/A
3.27
N/A
1.01
9.74
28.3
10.54
2.45
3.16
1.16
Standard Deviation
0.7688
2.06
0.8662
1.01
3.46
7.78
2.91
1.29
1.87
1.43
Kurtosis
22.2
5.42
13.1
0.4717
3.9
3.55
1.44
6.78
1.2
5.57
Potential Upside
0.3597
3.24
0.3246
1.86
5.87
16.3
4.07
2.09
3.52
2.34
Treynor Ratio
0.5773
0.3801
(0.26)
0.366
0.4341
1.01
0.1305
0.0742
0.2462
0.568
Maximum Drawdown
5.18
10.75
6.98
5.2
20.36
47.83
12.87
8.19
10.05
7.57
Variance
0.591
4.26
0.7503
1.02
11.97
60.47
8.44
1.67
3.51
2.04
Market Risk Adjusted Performance
0.5873
0.3901
(0.25)
0.376
0.4441
1.02
0.1405
0.0842
0.2562
0.578
Risk Adjusted Performance
(0.01)
0.064
(0.03)
0.1913
0.1966
0.248
0.0501
0.0417
0.1293
0.1964
Skewness
1.57
1.24
(0.96)
(0.21)
0.7068
1.25
(0.46)
(1.66)
0.1988
1.54
Semi Deviation
N/A
1.57
N/A
0.7433
2.36
4.08
3.11
1.49
1.54
0.6145
Information Ratio
(0.18)
0.0123
(0.19)
0.1178
0.2092
0.2958
0.0111
(0.05)
0.0918
0.1595
Value At Risk
(0.43)
(2.55)
(0.85)
(1.73)
(4.39)
(6.53)
(4.69)
(1.85)
(2.75)
(1.38)
Expected Short fall
N/A
(1.42)
N/A
(0.90)
(2.65)
(6.89)
(2.10)
(0.86)
(1.54)
(1.11)
Downside Deviation
N/A
1.81
N/A
1.0
3.12
5.32
3.25
1.57
1.78
1.08
Semi Variance
N/A
2.46
N/A
0.5525
5.58
16.63
9.65
2.22
2.36
0.3777

42225UAD6 Competition Performance Charts

Five steps to successful analysis of 42225UAD6 Competition

42225UAD6's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by HEALTHCARE TR AMER in relation to its competition. 42225UAD6's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of 42225UAD6 in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact 42225UAD6's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to HEALTHCARE TR AMER, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your 42225UAD6 position

In addition to having 42225UAD6 in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Hedge Favorites Thematic Idea Now

Hedge Favorites
Hedge Favorites Theme
Hedge Funds pool capital from accredited individuals or institutional investors and invest in a variety of assets, often with complex portfolio-construction and risk-management techniques. The Hedge Favorites theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Hedge Favorites Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in 42225UAD6 Bond

42225UAD6 financial ratios help investors to determine whether 42225UAD6 Bond is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in 42225UAD6 with respect to the benefits of owning 42225UAD6 security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY